Using seawater to treat infant bronchiolitis
Official title: Bronchiolitis Clearance Airways With Seaserum : a Doubled Blind Randomized Study
Run by University Hospital, Brest · NCT06177197 · Data updated 2026-11-12
This study is testing if using electrodialyzed seawater can help reduce symptoms in infants with bronchiolitis better than regular saline solution.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Month to 1 Year |
| Sex | All |
| Enrollment | 458 (estimated) |
| Sponsor | University Hospital, Brest Academic / other |
| Locations | 8 sites (Brest and 7 other locations) |
| Status | Recruiting |
| Started | January 10, 2025 |
| Main results expected | November 1, 2027 |
| Study ends | December 1, 2028 |
| Registry record updated | December 17, 2025 |
| Trial ID | NCT06177197 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are infants aged 1 month to less than 1 year experiencing their first episode of acute bronchiolitis with mild to moderate symptoms.
✕Probably not a fit
Patients with severe bronchiolitis or those who do not meet the inclusion criteria will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to determine if electrodialyzed seawater can reduce the duration of symptoms in infants with acute bronchiolitis compared to saline solution. It is a multicenter, prospective, controlled, randomized, double-blind study involving infants aged 1 month to less than 1 year. Participants will be randomly assigned to receive either the experimental treatment or the control treatment, and their parents will be contacted for follow-up assessments at specified intervals after treatment. The study focuses on infants experiencing their first episode of mild to moderate bronchiolitis.
Why it matters
Potential benefit: If successful, this treatment could provide a more effective and natural option for alleviating symptoms of bronchiolitis in infants.
How similar studies have gone: While the use of seawater in medical treatments is not widely tested, similar studies exploring alternative treatments for respiratory conditions have shown promise.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants aged more than 1 month and less than 1 year * First episode of acute bronchiolitis * Emergency consultation * Existence of nasal obstruction * Onset of symptoms \&lt; 48 hours before emergency consultation * Outpatient care after emergency consultation * Mild to moderate bronchiolitis according to the \&#34;Haute Autorité de Santé 2019\&#34; criteria: Respiratory rate over 1 minute \&gt;30/minutes and \&lt;60/minute ; Heart rate \&gt;80/minutes and \&lt;180/minutes; Absence of respiratory pauses; Absence of superficial breathing; Absence of signs of intense respiratory struggle: involvement of the lower intercostal accessory muscles, sternocleidomastoid muscles, thoracoabdominal swinging, or flapping of the wings of the nose; Feeding \&gt;50% of the usual quantity over 3 consecutive doses; SpO2 \&gt; 92% during sleep ; \&gt;94% when awake; \&gt;2 months corrected age * Parental consent * Affiliate to a social security system Exclusion Criteria: * Hospitalization (excluding short stay unit) after emergency consultation * Oxygen therapy * History of prematurity (birth \<36 weeks of amenorrhea) * History of invasive ventilation in the neonatal period * History of chronic pulmonary or cardiac pathology * History of immune deficiency * History of polyhandicap or neuromuscular pathology * History of malformative Ear Nose and Throat pathology affecting the upper airways * Impossibility of ensuring the follow-up made necessary by participation in this study
Where it's running
-
Brest, University Hospital
Brest, France Recruiting -
Le Mans hospital
Le Mans, France Recruiting -
Saint-Joseph hospital
Marseille, France Recruiting -
Morlaix hospital
Morlaix, France Recruiting -
Nantes, University Hospital
Nantes, France Recruiting -
Rennes, University hospital
Rennes, France Recruiting
Show 2 more locations
-
Tours, University hospital
Tours, France Recruiting -
Lille, University hospital
Lille, France Not yet recruiting
Study contacts
- Study coordinator: Pierrick CROS, MD
- Email: pierrick.cros@chu-brest.fr
- Phone: +33298223659
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using lung ultrasound and breathing-volume measurements to improve care for infants with lower respiratory infections
This project will try lung ultrasound and tidal-flow volume measurements to see if they give clearer, objective information for infants and young children with lower respiratory infections.
-
I-DECIDE: follow-up options after a child’s bronchiolitis hospitalization
This trial tests two ways hospitals can encourage doctors to prescribe on‑as‑needed (PRN) follow-up instead of routine automatic visits for children hospitalized with bronchiolitis to see if families attend fewer unnecessary clinic visits.
-
Unified care and integrated treatments for ADHD with substance use in prison settings
Aimed at people under correctional supervision who have ADHD and substance use disorder, this program tests a coordinated care approach to improve identification and support.
-
4D dynamic LAFOV FDG-PET to tell leftover cancer from post-radiation inflammation in head and neck squamous cell carcinoma
This study will test whether a 4D dynamic long‑axial‑field‑of‑view FDG‑PET scan can tell remaining head and neck squamous cell cancer from normal post‑radiation inflammation in adults about three months after finishing curative radiotherapy.
-
Imaging the anatomy of the eye socket (orbit)
This project looks at existing orbital imaging from adults to see how the eye muscles, optic nerve, and orbital fat are arranged.
-
Combining European cohort data to find biomarkers that guide treatment for venous thromboembolism
This project combines clinical, biological and imaging data from European patient cohorts to try to find biomarkers that predict clot recurrence, bleeding, or death in people with venous thromboembolism.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.